Insider Trading activities of Arbutus Biopharma Corp insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Arbutus Biopharma Corp since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Arbutus Biopharma Corp since year 2005. Table 2 shows the detailed insider transactions of Arbutus Biopharma Corp since 2005. The reporting company's ticker symbol is ABUS. The reporting company's CIK number is 1447028.
The total value of stock buying since 2005 is $6,950.
The total value of stock sales since 2005 is $191,390.
The total value of stock option exercises since 2005 is $109,898.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Arbutus Biopharma Corp (ABUS).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-10 0 $0 10,000 $80,000 0 $0
2017-08 0 $0 30,000 $111,390 0 $0
2016-08 0 $0 0 $0 14,178 $4,905
2015-09 0 $0 0 $0 236,472 $104,993
2015-08 1,000 $6,950 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Arbutus Biopharma Corp insiders (ABUS)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-10-03 Sofia Michael J. (Chief Scientific Officer) Sale 10,000 8.00 80,000
2017-08-15 Sofia Michael J. (Chief Scientific Officer) Sale 30,000 3.71 111,390
2016-08-16 Abrams Michael J. (Managing Director) Option Ex 14,178 .35 4,905
2015-09-11 Murray Mark J. (President & CEO) Option Ex 219,428 .44 97,426
2015-09-11 Abrams Michael J. (Managing Director) Option Ex 17,044 .44 7,567
2015-08-24 Henriques Richard C Jr Buy 1,000 6.95 6,950

Insider trading activities including stock purchases, stock sales, and option exercises of ABUS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Arbutus Biopharma Corp (symbol ABUS, CIK number 1447028) see the Securities and Exchange Commission (SEC) website.